View the Q3 2024 issue of WatersTechnology. View the Q2 2024 issue of WatersTechnology. View the Q1 2024 issue of WatersTechnology. View the Q4 2023 issue of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

A U.S. appeals court on Monday appeared open to upholding a federal rule requiring commercial fishermen to fund a program to monitor for overfishing of herring off New England's coast even after ...

The latest digital edition of Skagit Valley Herald is now available online. You can read it right now by clicking the button above. As a subscriber you have 24/7 access to the Skagit Valley Herald ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved two new indications for KEYTRUDA ® (pembrolizumab), Merck ...

A panel of advisors to the Food and Drug Administration (FDA) reportedly expressed concerns about the efficacy of Merck & Company, Inc.'s (NYSE: MRK) new drug gefapixant, intended to treat chronic ...

Check out what’s new with our refreshed design. If you use one of our e-Edition specific apps, you can continue using the same app but will notice some changes. Popular features such as double ...

RAHWAY, N.J. & CAMBRIDGE, Mass., October 28, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), today ...

To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan. Investing.com -- Merck and Co. (NYSE ...